Quantitative and qualitative alterations of circulating myeloid cells and plasmacytoid DC in SARS‐CoV‐2 infection

B Peruzzi, S Bencini, M Capone, A Mazzoni… - …, 2020 - Wiley Online Library
SARS‐CoV‐2 is responsible for a new infectious disease (COVID‐19) in which individuals
can either remain asymptomatic or progress from mild to severe clinical conditions including …

Quantitative and qualitative alterations of circulating myeloid cells and plasmacytoid DC in SARS‐CoV‐2 infection.

B Peruzzi, S Bencini, M Capone, A Mazzoni… - …, 2020 - search.ebscohost.com
SARS‐CoV‐2 is responsible for a new infectious disease (COVID‐19) in which individuals
can either remain asymptomatic or progress from mild to severe clinical conditions including …

Quantitative and qualitative alterations of circulating myeloid cells and plasmacytoid DC in SARS-CoV-2 infection

B Peruzzi, S Bencini, M Capone, A Mazzoni… - …, 2020 - pubmed.ncbi.nlm.nih.gov
SARS-CoV-2 is responsible for a new infectious disease (COVID-19) in which individuals
can either remain asymptomatic or progress from mild to severe clinical conditions including …

Quantitative and qualitative alterations of circulating myeloid cells and plasmacytoid DC in SARS-CoV-2 infection

B Peruzzi, S Bencini, M Capone, A Mazzoni, L Maggi… - IMMUNOLOGY, 2020 - flore.unifi.it
SARS-CoV-2 is responsible for a new infectious disease (COVID-19) in which individuals
can either remain asymptomatic or progress from mild to severe clinical conditions including …

[HTML][HTML] Quantitative and qualitative alterations of circulating myeloid cells and plasmacytoid DC in SARS‐CoV‐2 infection

B Peruzzi, S Bencini, M Capone, A Mazzoni, L Maggi… - …, 2020 - ncbi.nlm.nih.gov
SARS‐CoV‐2 is responsible for a new infectious disease (COVID‐19) in which individuals
can either remain asymptomatic or progress from mild to severe clinical conditions including …

Quantitative and qualitative alterations of circulating myeloid cells and plasmacytoid DC in SARS-CoV-2 infection.

B Peruzzi, S Bencini, M Capone, A Mazzoni, L Maggi… - Immunology, 2020 - europepmc.org
SARS-CoV-2 is responsible for a new infectious disease (COVID-19) in which individuals
can either remain asymptomatic or progress from mild to severe clinical conditions including …

Quantitative and qualitative alterations of circulating myeloid cells and plasmacytoid dc in SARS-CoV-2 infection.

B Peruzzi, S Bencini, M Capone, A Mazzoni, L Maggi… - 2020 - cabidigitallibrary.org
SARS-CoV-2 is responsible for a new infectious disease (COVID-19) in which individuals
can either remain asymptomatic or progress from mild to severe clinical conditions including …